Jim Weterings
Company: Sirnaomics Inc.
Job title: Vice President Research, RNA Therapeutics & Delivery
Seminars:
GalAhead™: A Proprietary GalNAc-RNAi Therapeutic Platform to Downregulate Single & Multiple Genes 9:00 am
• Introduction to GalAhead, Sirnaomics’ GalNAc-RNAi therapeutic platform • Validation of technology in vivo and in vitro • Progress report on GalAhead-based programsRead more
day: Conference Day Two